EDITORIAL
Published on 18 Sep 2023
Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
doi 10.3389/fendo.2023.1287807
- 1,263 views
- 1 citation
- Frontiers in Endocrinology
- Diabetes: Molecular Mechanisms
- Research Topics
- Pharmacogenomics and Pharmacomicrobiomics in Type 2 Diabetes Mellitus (T2DM)
Pharmacogenomics and Pharmacomicrobiomics in Type 2 Diabetes Mellitus (T2DM)
14k
Total downloads
40k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 23 Aug 2023
Gene–diet interaction analysis using novel weighted food scores discovers the adipocytokine signaling pathway associated with the development of type 2 diabetes
doi 10.3389/fendo.2023.1165744
- 1,966 views
- 2 citations
REVIEW
Published on 09 May 2023
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
doi 10.3389/fendo.2023.1114424
- 11,211 views
- 53 citations
REVIEW
Published on 23 Mar 2023
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
doi 10.3389/fendo.2023.1149256
- 2,692 views
- 6 citations
CLINICAL TRIAL
Published on 17 Feb 2023
Probiotics intervention in preventing conversion of impaired glucose tolerance to diabetes: The PPDP follow-on study
doi 10.3389/fendo.2023.1113611
- 2,273 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Jan 2023
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
doi 10.3389/fendo.2023.1026040
- 3,667 views
- 16 citations
ORIGINAL RESEARCH
Published on 14 Nov 2022
Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance
doi 10.3389/fendo.2022.1031019
- 1,339 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Aug 2022
Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
doi 10.3389/fendo.2022.949990
- 2,117 views
- 7 citations
PERSPECTIVE
Published on 07 Jul 2022
Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?
doi 10.3389/fendo.2022.898878
- 2,633 views
- 7 citations
REVIEW
Published on 04 May 2022
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
doi 10.3389/fendo.2022.857090
- 4,410 views
- 12 citations
